Modeling of drug diffusion in a solid tumor leading to tumor cell death
It has been shown recently that changing the fluidic properties of a drug can improve its efficacy in ablating solid tumors. We develop a modeling framework for tumor ablation, and present the simplest possible model for drug diffusion in a spherical tumor with leaky boundaries and assuming cell death eventually leads to ablation of that cell effectively making the two quantities numerically equivalent. The death of a cell after a given exposure time depends on both the concentration of the drug and the amount of oxygen available to the cell. Higher oxygen availability leads to cell death at lower drug concentrations. It can be assumed that a minimum concentration is required for a cell to die, effectively connecting diffusion with efficacy. The concentration threshold decreases as exposure time increases, which allows us to compute dose-response curves. Furthermore, these curves can be plotted at much finer time intervals compared to that of experiments, which is used to produce a dose-threshold-response surface giving an observer a complete picture of the drug's efficacy for an individual. In addition, since the diffusion, leak coefficients, and the availability of oxygen is different for different individuals and tumors, we produce artificial replication data through bootstrapping to simulate error. While the usual data-driven model with Sigmoidal curves use 12 free parameters, our mechanistic model only has two free parameters, allowing it to be open to scrutiny rather than forcing agreement with data. Even so, the simplest model in our framework, derived here, shows close agreement with the bootstrapped curves, and reproduces well established relations, such as Haber's rule.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Geometric immunosuppression in CAR-T cell treatment: Insights from mathematical modeling
Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a promising treatment for hematological malignancies, offering a targeted approach to cancer treatment. Understanding the complexities of CAR-T cell therapy…
Cross-domain feature disentanglement for interpretable modeling of tumor microenvironment impact on drug response
High-throughput screening technology has facilitated the generation of large-scale drug responses across hundreds of cancer cell lines. However, there exists significant discrepancy between in vitro cell lines and actual…
DenoisingDisentanglementDomain AdaptationGraph AttentionMathematical Modeling Insights into Improving CAR T cell Therapy for Solid Tumors: Antigen Heterogeneity and Bystander Effects
As an adoptive cellular therapy, Chimeric Antigen Receptor T-cell (CAR T-cell) therapy has shown remarkable success in hematological malignancies, but only limited efficacy against solid tumors. Compared with blood cance…
A Bayesian Model of Dose-Response for Cancer Drug Studies
Exploratory cancer drug studies test multiple tumor cell lines against multiple candidate drugs. The goal in each paired (cell line, drug) experiment is to map out the dose-response curve of the cell line as the dose lev…
DenoisingDrug DiscoveryExperimental DesignImputationNExT-Mol: 3D Diffusion Meets 1D Language Modeling for 3D Molecule Generation
3D molecule generation is crucial for drug discovery and material design. While prior efforts focus on 3D diffusion models for their benefits in modeling continuous 3D conformers, they overlook the advantages of 1D SELFI…
3D Generation3D Molecule GenerationDrug DiscoveryLanguage Modeling+2